Dr. Aaron Burberry's lab at Case Western Reserve University focuses on understanding the role of T cells in Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). The research aims to uncover how genetic mutations, particularly in the C9ORF72 gene, and environmental factors such as gut bacteria impact T cell behavior and contribute to disease progression. By exploring these mechanisms, the lab hopes to identify new therapeutic strategies and biomarkers for these neurodegenerative disorders.

Dr. Leon Maing Tai's research lab at the University of Illinois at Chicago focuses on understanding how specific genetic factors impact the health of blood vessels in the brain, particularly in the context of diseases like Alzheimer's. By studying the role of a protein called APOE, which comes in different forms that affect brain function, the lab aims to uncover the underlying mechanisms of neurovascular dysfunction that leads to cognitive decline. This research is significant as it may lead to new insights and therapies for neurodegenerative diseases related to aging.

Dr. Adel M. Talaat's research lab at the University of Wisconsin-Madison focuses on understanding tuberculosis and its interactions with other infections, particularly COVID-19. The lab aims to improve the efficacy of tuberculosis vaccines using innovative mRNA technology and nanoparticle delivery systems. By studying these interactions in mouse models, the research could lead to better control strategies for both diseases, significantly impacting public health.

Dr. Yao Liang Tang's lab studies how specific enzymes affect heart cells after injury. They focus on transforming problematic heart cells into those that can help repair heart damage. This research is important because it could lead to new treatments for heart failure, a condition where the heart struggles to pump blood effectively.

Dr. Qing Tang's lab studies a specific type of bacteria, Staphylococcus aureus, that can be particularly harmful to patients with cystic fibrosis. They focus on how certain genetic changes in these bacteria allow them to survive and cause inflammation in the lungs of these patients. By understanding the metabolism and structure of these bacteria, the lab aims to uncover new ways to treat and manage chronic infections in cystic fibrosis patients.

Dr. Allison Kraus leads a research lab focused on understanding tau misfolding in neurodegenerative diseases like Alzheimer's and other dementias. The lab investigates how tau aggregates form and interact at the cellular level, aiming to identify biomarkers for early diagnosis and to find novel therapeutic targets. Their work combines advanced protein detection techniques with innovative approaches to study brain and skin samples.

Dr. Jonathan D. Cherry's lab at Boston University Medical Campus focuses on understanding the effects of repetitive head injuries (RHI) on the brain, particularly concerning a condition known as chronic traumatic encephalopathy (CTE). The lab uses advanced techniques to study how tau protein accumulates in the brain after such injuries and how this influences neuroinflammation and neurodegeneration. Their research aims to elucidate the mechanisms linking RHI and tau pathology, hoping to lead to better treatments and diagnostic markers for CTE and related diseases.

Dr. Daewoo Lee's lab at Ohio University focuses on understanding Alzheimer's disease through the study of tau proteins, which become abnormal in this condition. The research investigates how tau proteins are released from neurons and how they contribute to the spread of Alzheimer's disease. By using model systems like Drosophila and human cell lines, the lab aims to uncover the molecular mechanisms behind tau release and propagation, paving the way for potential new therapies.

Dr. Scott Brady's lab at the University of Illinois at Chicago focuses on understanding and developing treatments for neurodegenerative diseases, particularly those related to tau protein dysfunction like Alzheimer's and frontotemporal dementia. The lab is exploring how misfolded tau proteins disrupt normal brain functions and contributes to disease. By using chemical compounds to target specific mechanisms of tau toxicity, the lab aims to identify potential therapeutic strategies that could help restore neuronal function.

Dr. Sohail F. Tavazoie's lab at Rockefeller University focuses on understanding the biology and genetics behind the process of metastasis, which is how cancer spreads from its original site to other parts of the body. By examining how certain genetic variants and microRNAs influence metastasis, the lab aims to identify critical pathways that could lead to new therapies for cancer. Their work has significant implications for developing targeted treatments that can prevent or reduce metastasis in various cancers.

Dr. Savas Tay's lab at the University of Chicago focuses on how cells communicate and process information in complex environments. The lab combines experimental techniques with advanced technologies to analyze single cells, particularly in the context of immune signaling in health and disease. By understanding these processes, the research aims to improve therapies for various conditions, including cancer and autoimmune diseases.

Dr. Silvia Porta Antolinez's lab at the University of Pennsylvania studies the role of a protein called TDP-43 in brain diseases, particularly in age-related dementias like frontotemporal lobar degeneration (FTLD) and Alzheimer's disease. They focus on understanding the differences and behaviors of TDP-43 across various brain conditions and how these differences might help in developing better diagnostic and therapeutic strategies for dementia.

Dr. Kathy L Newell's research lab at Indiana University Indianapolis focuses on understanding the role of TDP-43 protein in various neurodegenerative diseases, such as Frontotemporal Lobar Degeneration (FTLD) and Amyotrophic Lateral Sclerosis (ALS). By investigating the molecular changes and mislocalization of TDP-43, her team aims to uncover the mechanisms behind different clinical presentations of these diseases. Their innovative approach combines advanced imaging and molecular techniques to study the structure and modifications of TDP-43, which could lead to new diagnostic and therapeutic strategies.

Dr. Sam R Telford's lab focuses on enhancing biosafety and biocontainment in research related to infectious diseases. The team trains staff in advanced technical skills required for working with dangerous pathogens and develops resources to enable rapid responses to emerging health threats, such as pandemics. By fostering collaboration with academic and industry partners, the lab aims to improve regional preparedness in managing public health challenges.

Dr. Titia De Lange's lab at Rockefeller University studies how telomeres—the protective caps at the ends of chromosomes—affect cancer and cellular aging. They investigate the mechanisms behind genome instability in tumors caused by telomere shortening, and how this can lead to issues such as replicative senescence, which limits cell proliferation. Their research aims to provide insights that could potentially inform cancer treatments and preventive strategies.

Dr. Keisuke Ito's lab focuses on understanding the role of the Tet2 gene in hematopoietic stem cells, which are essential for producing blood cells. They study how mutations in Tet2 can lead to disorders like myelodysplastic syndrome (MDS), a disease where blood production is impaired. By using genetically modified mouse models, the lab aims to uncover the molecular mechanisms by which Tet2 functions, contributing to better treatments for blood-related diseases.

Dr. S. Murray Sherman's lab at the University of Chicago focuses on the interactions between the thalamus and the cortex in the brain, specifically how these structures communicate to influence sensory processing and cognitive functions. The research aims to uncover the role of lesser-known thalamic nuclei in the flow of information across cortical areas, which could provide insights into cognitive disorders such as schizophrenia and Alzheimer's disease.

Dr. Bruce L. Goode's lab at Brandeis University focuses on understanding how the actin cytoskeleton, a crucial component of cells, is regulated and how it interacts with other structures within cells. The researchers use advanced techniques to study dynamic changes in actin in real time, which is essential for important processes like cell movement and division. By exploring how mutations in genes related to actin dynamics contribute to diseases like cancer and neurodegeneration, the lab aims to uncover insights that could lead to new therapeutic strategies.

Dr. Vishwa Deep Dixit's lab focuses on understanding how aging and inflammation are linked to chronic diseases. By investigating the role of Fibroblast Growth Factor 21 (FGF21) and its receptor Klotho, the lab aims to uncover new strategies to enhance healthspan and lifespan by reducing age-related inflammation and metabolic dysfunction. The research includes exploring how FGF21 can be used therapeutically to combat the effects of aging.

Dr. Inma Cobos' research lab at Stanford focuses on understanding how different brain cells respond to Alzheimer's disease. By studying humanized mouse models, the lab aims to identify which types of brain cells are especially vulnerable to the disease and how they interact with each other. Their work will help uncover the mechanisms that lead to cognitive deficits and advance the understanding of Alzheimer's pathology.